Pelvic actinomycosis in users of intrauterine contraception
Cellár, D.; Garaj, J.
Ceskoslovenska Gynekologie 50(9): 671-673
1985
ISSN/ISBN: 0374-6852 PMID: 4084990 Document Number: 423952
Document emailed within 1 workday
Related Documents
Spagnuolo, P.J.; Fransioli, M. 1981: Intrauterine device-associated actinomycosis simulating pelvic malignancy American Journal of Gastroenterology 75(2): 144-147White, T.; Felix, J.C. 2007: Pelvic actinomycosis with retained intrauterine fetal bone: a case report Journal of Reproductive Medicine 52(3): 220-222
Kohoutek, M.; Nozicka, Z. 1978: Tubal actinomycosis as a complication of intrauterine contraception Zentralblatt für Gynakologie 100(3): 179-182
Ugezu, C.H.; Kelly, I.; Walker, F.; Stratton, J.F. 2012: A case of pelvic actinomycosis with bilateral hydronephrosis and renal failure associated with prolonged intrauterine contraceptive systems use Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 32(4): 403-404
Viberga, I.; Odlind, V.; Berglund, L. 2005: "Older" age is a risk factor for pelvic inflammatory disease in intrauterine device users Acta Obstetricia et Gynecologica Scandinavica 84(12): 1202-1207
Calzolari, E.; Girolametti, C.; Parisi, C.; Iannucci, D.; Steffè, M.; Ciampaglia, G. 1988: Experience with intrauterine contraception. Survey of 600 IUD users at the S. Anna University Hospital in Rome Minerva Ginecologica 40(5): 317-320
Struthers, B.J. 1985: Pelvic inflammatory disease, intrauterine contraception, and the conduct of epidemiologic studies Advances in Contraception: the Official Journal of the Society for the Advancement of Contraception 1(1): 63-76
Li, B.Z.; Zhang, Y.J.; Zhang, Z.M. 1994: Clinico-pathologic study of 285 cases of ectopic pregnancy in intrauterine devices-users and non-intrauterine devices-users Zhonghua Fu Chan Ke Za Zhi 29(4): 238-240; 255
Wildemeersch, D.; Pett, A.; Jandi, S.; Hasskamp, T.; Rowe, P.; Vrijens, M. 2013: Precision intrauterine contraception may significantly increase continuation of use: a review of long-term clinical experience with frameless copper-releasing intrauterine contraception devices International Journal of Women's Health 5: 215-225
Wildemeersch, D.; Pett, A.; Jandi, S.; Hasskamp, T.; Rowe, P.; Vrijens, M. 2013: Precision intrauterine contraception may significantly increase continuation of use: a review of long-term clinical experience with frameless copper-releasing intrauterine contraception devices International Journal of Women's Health 5: 215-225
Wildemeersch, D.; Pett, A.; Jandi, S.; Hasskamp, T.; Rowe, P.; Vrijens, M. 2013: Precision intrauterine contraception may significantly increase continuation of use: a review of long-term clinical experience with frameless copper-releasing intrauterine contraception devices International Journal of Women's Health 5: 215-225
Wildemeersch, D.; Pett, A.; Jandi, S.; Hasskamp, T.; Rowe, P.; Vrijens, M. 2013: Precision intrauterine contraception may significantly increase continuation of use: a review of long-term clinical experience with frameless copper-releasing intrauterine contraception devices International Journal of Women's Health 5: 215-225
Wildemeersch, D.; Pett, A.; Jandi, S.; Hasskamp, T.; Rowe, P.; Vrijens, M. 2013: Precision intrauterine contraception may significantly increase continuation of use: a review of long-term clinical experience with frameless copper-releasing intrauterine contraception devices International Journal of Women's Health 5: 215-225
Wildemeersch, D.; Pett, A.; Jandi, S.; Hasskamp, T.; Rowe, P.; Vrijens, M. 2013: Precision intrauterine contraception may significantly increase continuation of use: a review of long-term clinical experience with frameless copper-releasing intrauterine contraception devices International Journal of Women's Health 5: 215-225
Wildemeersch, D.; Pett, A.; Jandi, S.; Hasskamp, T.; Rowe, P.; Vrijens, M. 2013: Precision intrauterine contraception may significantly increase continuation of use: a review of long-term clinical experience with frameless copper-releasing intrauterine contraception devices International Journal of Women's Health 5: 215-225
Parra, A.; Gabiño, F.; Ramírez, A.; Valencia, H.; Coria, I.; Espinosa de los Monteros, A. 1991: Basal and metoclopramide-stimulated prolactin (PRL) serum levels in users and non-users of a copper intrauterine device (TCu-380 IUD) Contraception 44(5): 541-547
Parra, A.; Gabiño, F.; Ramírez, A.; Valencia, H.; Coria, I.; Espinosa de los Monteros, A. 1991: Basal and metoclopramide-stimulated prolactin (PRL) serum levels in users and non-users of a copper intrauterine device (TCu-380 IUD) Contraception 44(5): 541-547
Davies, A.; Fleming, C. 2014: Do intrauterine device/intrauterine system users check their threads? Journal of Family Planning and Reproductive Health Care 40(2): 122-125
Kakkos, A.; Gonne, E.; Coimbra, C.; Nervo, P.; Remacle, G.; Thille, A.; Hayette, M.P.; Van Linthout, C.; Kridelka, F.; Delbecque, K. 2017: Pseudotumoral pelvic actinomycosis : one should think of it Revue Medicale de Liege 72(1): 10-13
Daaloul, W.; Hamdi, N.; Ouerdiane, N.; Masmoudi, A.; Ben Hamouda, S.; Ennine, I.; Bouguerra, B.; Sfar, R. 2012: Tumor-like pelvic actinomycosis La Tunisie Medicale 90(11): 830-831